DRUG
placebo (compared to vasoconstrictor)
intranasal administration of placebo (4 sprays of 0.9% saline and glycerin)
Status
Recruiting
Phase
Not applicable
Enrollment
120
Locations
1
Results
Not posted
Publications
0
Study summary
The main goal of this study is to investigate the modulatory effects of intranasally administrated oxytocin on the processing of emotional stimuli and its acting routes.
In recent years ample studies have reported that intranasally administered oxytocin (OT) can facilitate social motivation and cognition in healthy and clinical populations. However, it is still unclear how effects are mediated since intranasally administered OT can both directly enter the brain (nose to brain) and increase peripheral vascular concentrations (nose to blood). The relative functional contributions of these routes are not established and have received insufficient attention in the field. Therefore, the investigators use the vasoconstrictor (VC) pretreatment to prevent intranasal OT (24 IU) from increasing peripheral concentrations and combine fMRI, behavioral measures, with physiological recording to examine the modulatory effects of OT on implicit emotional processing and its acting routes. In total 120 male participants are recruited for this double-blind, between-subject, placebo-controlled study. After arriving at the laboratory, participants first completed questionnaires for about 30 minutes, and were then randomly assigned into 3 groups receiving intranasal administration of "VC + OT", "placebo (PLC) + OT", or "VC + PLC". Then, they complete a resting-state scan and two task-based scans lasting approximately 65 minutes in total. There is a sencond resting-state scan between two task-based scans, which is mainly used as a break between the two tasks. Blood samples are collected twice (after finishing questionnaires and 30 minutes post-treatment) for subsequent analyses of plasma OT concentrations. The two task-based scans consist of an implicit face-emotion processing task (gender judgments of faces) and an emotional scene processing task (judging whether a child/old people/building/dog is present in the picture). After scanning, there is a 40-minute picture rating task (emotional valence, intensity, and arousal). Questionnaires include State-Trait Anxiety Inventory, Beck Depression Inventory II, Liebowitz Social Anxiety Scale, Autism Spectrum Quotient, Social Responsiveness Scale-2, Interpersonal Reactivity Index, Childhood Trauma Questionnaire, Toronto Alexithymia Scale and Positive and Negative Affect Schedule.
Interventions
DRUG
intranasal administration of placebo (4 sprays of 0.9% saline and glycerin)
DRUG
intranasal administration of vasoconstrictor (4 sprays of 0.9% Otrivin)
DRUG
intranasal administration of placebo (24 IU)
DRUG
intranasal administration of oxytocin (24IU)
Timeline
First posted
Feb 23, 2026
Study start
Jan 24, 2026
Primary completion
Apr 15, 2026
Study completion
Apr 15, 2026
Results posted
Not reported
Registry updated
Feb 23, 2026
Outcomes
Brain activity in response to emotional stimuli during task-based fMRI scanning
Time frame · 1 hour
Subjects receive task fMRI scanning after treatment. The investigators will compare the activation differences in the brain, specifically focusing on the amygdala, among three groups.
Changes in plasma oxytocin concentrations
Time frame · After finishing questionnaires and 30-minute post-treatment
Blood samples will be collected two times, with one sample collected after finishing questionnaires and the other one 30-minute post-treatment.
The valence rating in response to different emotional stimuli
Time frame · 40 minutes
The valence rating scores (1\~9) were collected in response to neutral, positive or negative emotional pictures. The higher the score (5\~9), the more positive the participants consider the picture to be; the lower the score (1\~5), the more negative the participants consider the picture to be. The rating scores will be collected after fMRI scanning.
The intensity rating in response to different emotional stimuli
Time frame · 40 minutes
The intensity rating scores (1\~9) were collected in response to neutral, positive or negative emotional pictures. The higher the score, the stronger the intensity level. The rating scores will be collected after fMRI scanning.
The arousal rating in response to different emotional stimuli
Time frame · 40 minutes
The arousal rating scores (1\~9) were collected in response to neutral, positive or negative emotional pictures. The higher the score, the stronger the arousal level. The rating scores will be collected after fMRI scanning.
Resting-state fMRI
Time frame · 17 minutes in total with each lasting around 8.5 minutes.
Subjects receive resting-state fMRI scanning before and after first task, with the sencond resting-state scan being mainly used as a break between the two tasks. The investigators will compare the resting-state functional connectivity (the amygdala as the seed region) among three groups.
Eligibility
Inclusion Criteria: * Healthy subjects without past or current psychiatric or neurological disorders Exclusion Criteria: * History of head injury. * Medical or psychiatric illness. * Subjects take a certain drug for a long period of time. * Subjects have metal implants in their bodies.
Study locations
China. Showing up to 24 locations stored in the fast local snapshot.
University of Electronic Science and Technology of China (UESTC)
Chengdu, Sichuan, China
Publications
No PMID-linked publications were present in this registry snapshot.
Related trials
Wake Forest University Health Sciences · Total Hip Arthroplasty
Phase 2
Enrolling by invitation
80
2026-07
Yale University · Pain · Pituitary Surgery
Phase 2
Not yet recruiting
75
2026-07
Medical University of South Carolina · PTSD · Alcohol Use Disorder
Phase 2
Completed
175
2026-07
University Hospital, Tours · Cervical Ripening · Unfavorable Cervix
Phase 3
Recruiting
1,494
2026-07
Icahn School of Medicine at Mount Sinai · Pregnancy · Labor
Phase 3
Recruiting
281
2026-07
Elizabeth Austen Lawson · Vasopressin Deficiency
Phase 1
Recruiting
40
2026-07
Massachusetts General Hospital · Arginine Vasopressin Deficiency · Oxytocin Deficiency
Early Phase 1
Recruiting
20
2026-07
Aalto University · Induction of Birth · Cervical Ripening
Not applicable
Recruiting
40
2026-07
Related PeptideStat pages
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.